Development of small molecule inhibitors/agonists targeting STING for disease.

导出 LinkOut

翻译打印收藏纠错

作者： Kaifeng,Liu ^[1] ; Yongqi,Lan ^[1] ; Xiaoling,Li ^[2] ; Mingyue,Li ^[3] ; Liao,Cui ^[4] ; Hui,Luo ^[5] ; Lianxiang,Luo ^[6]

作者单位： The First Clinical College, Guangdong Medical University, Zhanjiang 524023, China. ^[1] Animal Experiment Center of Guangdong Medical University, Zhanjiang, 524023, China. ^[2] Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. ^[3] Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China. ^[4] The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, 524023, China. ^[5] The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, 524023, China; The Marine Biomedical Research Institute of Guangdong Zhanjiang, Zhanjiang, Guangdong, 524023, China; Southern Marine Science and Engineering Guangdong Laboratory (Zhanjiang), Zhanjiang, Guangdong, 524023, China. Electronic address: luolianxiang321@163.com. ^[6]

关键词 Disease Innate immune response Small molecule agonists Small molecule inhibitors Stimulator of interferon genes